Abstract: Disclosed is a personal care composition comprising by weight: (a) from about 5% to about 35% of a hydrophobic gel comprising: (i) a cholesteryl derivative; (ii) an oil swelling clay material; (iii) a non-volatile liquid oil; and (iv) a polar solvent; and (b) a carrier which is substantially free of water, surfactant, and lecithin; which satisfies the need for a personal care composition having improved physical stability.

Abstract: The invention relates to parenteral dosage forms of administration that comprise a suspension of the salt of the active substances tramadol and diclofenac.

Abstract: The invention refers to a cosmetic product for hairs and decorative cosmetic with particular water resistance and wear (transfer) resistance. The product comprises stabile mixture of a water-emulsifiable, film-forming agent; a rheology modifier; a pigment; a volatile organic solvent; an oil soluble polymeric film-former; a silicon resin; and a filler.

Abstract: The present invention 10 discloses a method of applying, drying and bonding fingernail polish 26, and more particularly, to the bonding of protective coatings on a fingernail 16 by means of a prescribed process. The preferred method of the present invention 10 is to provide a simple but unique method of drying and bonding protective nail coatings that fortifies the fingernail. This unique method provides for long-lasting, non-yellowing, natural-looking nails 16 that can be worn with or without nail polish 26. The present invention 10 requires the use of instruments including: a UV lamp, acrylic drill, nail file, coarse and medium sanding paper, gel brush, scissors, flat brush, steel brush, cuticle pusher, orange stick, flat brush handle, and anything that is considered tube, squeeze instruments foil or plastic bag. As part of the method of the present invention 10, an acrylic powder blend is mixed with a UV gel compound to form a gel blend/mix.

Abstract: A pigment containing particles surface treated with N-acylglycine hydroxyaluminum and/or N-acyl-N-methylglycine hydroxyaluminum, and a pigment dispersion which contains such surface treated particles and a cosmetically acceptable oily material, having excellent dispersion stability and versatility (ease of dispersion and wide range of usage), because the particles are easily and uniformly dispersed in a short period of time at a high concentration in such a cosmetically acceptable oily material, thus a cosmetic product is thereby stable as an emulsion and has better usage than existing products.

Abstract: Bioadhesive, closed-cell foam film, sustained release, delivery devices for administering an active agent or combination of active agents to a subject are provided. Methods for making such delivery devices and to methods for using such delivery devices offering the controlled and sustained release of an active agent or combination of active agents to a subject, preferably a near zero-order release, are also provided.

Abstract: This invention relates to topical compositions and a glove for protection against radiation exposure, such as that due to radiation used in medical procedures.

Abstract: A solid cosmetic composition, which drastically improves the shape-retaining ability and usability, which has a good, tender feeling, good spreadability when applied and is glossy looking is provided by use of a wax composition solidifier, which has a good shape-retaining ability without use of a conventional solidifier such as ceresin is provided. A solid cosmetic composition has (a) Fischer-Tropsch wax having average molecular weight of 300 to 1200 and (b) Microcrystalline wax in the weight ratio of (a):(b)=60:40 to 99.9:0.

Abstract: Nail enamel compositions of the present invention for coating natural or synthetic human nails broadly include the ingredients of one or more film forming components, preferably nitrocellulose having a molecular weight greater than 56,000, one or more solvents and bismuth oxychloride.

Abstract: Improved ivermectin-containing daily ration extruded feeds for domesticated household pets such as cats and dogs are provided so that a pet consuming the feeds receives quantities of ivermectin sufficient to establish and maintain substantially constant concentrations of the drug in the pet's bloodstream. The feeds are produced by extrusion with addition of minor quantities of ivermectin so as to uniformly distribute the drug throughout the extruded product. Ivermectin levels of from about 2-1500 &mgr;g/kg of extruded feed are preferred.

Abstract: A wart, callus and/or corn removing pad including a layer of hydrocolloid adhesive material having a periphery and an underside, a medicated plaster secured centrally to the underside of the layer of hydrocolloid adhesive material and including salicylic acid therein, a barrier layer interposed between the medicated plaster and the layer of hydrocolloid adhesive material to prevent diffusion of the salicylic acid in the medicated plaster to the layer of hydrocolloid adhesive material, an outer layer secured to the layer of hydrocolloid material, the outer layer at least having a border extending outwardly of the layer of hydrocolloid adhesive material, the border having an underside, a layer of adhesive material on the underside of the border, a release liner releasably secured to the underside of the hydrocolloid adhesive layer, and a paper release tab releasably secured to an upper surface of at least one of the hydrocolloid adhesive layer and the outer layer at one side thereof.

Abstract: The present invention relates to compositions, kits, and films formed therefrom which are useful as cosmetic or therapeutic agents, as well as methods of their use. The compositions, kits, and films herein are particularly useful as polishes for mammalian nails. More particularly, the present invention relates to compositions and kits which, when applied to mammalian nails form films exhibiting long wear. When applied to mammalian nails, the present kits and compositions form films exhibiting surface energies from about 32 mN/m to about 43 mN/m and polarities from about 0.19 to about 0.29. The present invention further relates to methods of coating mammalian nails with films exhibiting surface energies from about 32 mN/m to about 43 mN/m and polarities from about 0.19 to about 0.29.

Abstract: Compositions and methods for treating keratin-related conditions and disorders such as straightening and styling hair, treating nail fungal conditions such as onychomycosis, ingrown nails, and hyperkeratotic conditions of the epidermis such as psoriasis, acne, callouses, corns, verruca, particularly plantar warts, and surface lines and blemishes of aging skin by aiding the exfoliation of keratinocytes. The compositions comprise at least one alkanoic acid in aqueous solution.

Abstract: A cosmetic hair composition comprising, in a cosmetically acceptable medium, at least one ceramide compound and at least one agent for screening out ultraviolet radiation containing at least one sulphonic acid radical. The invention also relates to a process of including a ceramide compound in a cosmetic hair composition containing a UV screening agent containing at least one sulphonic acid radical, in order to improve the fixing of the UV screening agent to the hair.

Abstract: An adhesive composition that contains cyanoacrylate monomers and cyclic or alkyl- or phenyl-terminated linear polydimethylsiloxane is particularly useful in applications requiring flexibility and elasticity.

Abstract: The present invention is drawn to inner esters of gellan, wherein the carboxy groups are esterified with hydroxy groups from either the same or different molecules of gellan. The present invention is further drawn to methods of using the present inner esters of gellan in the fields of cosmetics, pharmaceuticals and in sanitary and surgical articles. The present invention is further drawn to products made from inner esters of gellan and to be used in the indicated fields.

Abstract: The present invention provides greater than 99% pure bis(triorganosilyl)hydroxycarboxylates of the general formulae:R.sub.3 SiO--CHR.sup.1 --COO--SiR.sub.3R.sub.3 SiO--CHR.sup.1 --R.sup.2 COO--SiR.sub.3wherein each R is independently a monovalent straight or branched chain alkyl or alkenyl group having from 1 to about 6 carbon atoms, or an aryl group, R.sup.1 may be hydrogen, a monovalent straight or branched chain alkyl group having from 1 to about 18 carbon atoms, or an aryl group, and R.sup.

Abstract: The present invention relates to a cosmetic composition for treating keratin substances, in particular the hair, comprising at least one fixing polymer, at least 5% by weight of a non-volatile aryl silicone and at least one volatile silicone, as well as to a process for treating keratin substances using this composition.

Abstract: Cyanoacrylate preparations for medical and surgical applications are sterilized by heating in a suitable container at a temperature of at least 160.degree. C. The preferred container is a squeezable aluminum tube and the preferred temperature is above 170.degree. C. Cyanoacrylate adhesive compositions sterilized by heat have improved shelf life compared to those sterilized by ionizing radiation.

Abstract: Disclosed is a vaginal ring intended for the release of at least one drug over a prolonged time period. The vaginal ring contains a ring body made of a first polymeric material having at least one hollow internal channel defining an opening to the exterior of said body and which channel is adapted to receive a drug-containing core through said opening, and an intravaginally administerable drug-containing core disposed in the channel. The core is positioned in the vaginal ring body suitably prior to use in order to substantially avoid initial bursts of drug into the tissues of the subject and resultant side effects such as nausea and vomiting. The core contains a pharmaceutically effective amount of at least one intravaginally administerable drug dispersed in a second polymeric material. The first and second polymeric materials may be the same or different. Representative drugs include contraceptive agents and other steroidal substances for use in hormone replacement therapy.